E-LIB Suche - Ergebnisse für: Mai, Tu H.

1

Comparative Pharmacokinetics and Safety Assessment of 1st‐ ..:

Mai, Tu H. ; Yadav, Rajbharan ; Arjomandi, Audrey...
Clinical Pharmacology in Drug Development. 13 (2024) 6 - p. 655-664 , 2024

Link: https://doi.org/10.1002/..

2

Idiopathic pulmonary fibrosis therapy development: a clinic..:

Mai, Tu H. ; Han, Lyrialle W. ; Hsu, Joy C...
Therapeutic Advances in Respiratory Disease. 17 (2023) - p. , 2023

Link: https://doi.org/10.1177/..

3

Safety, Tolerability, and Pharmacokinetics of Benralizumab:..:

Cheung, Tommy Tsang ; Mai, Tu H ; Chia, Yen Lin...
Drug Design, Development and Therapy. 17 (2023) - p. 209-218 , 2023

Link: https://doi.org/10.2147/..

4

Relationship Between Anifrolumab Pharmacokinetics, Pharmaco..:

Chia, Yen Lin ; Tummala, Raj ; Mai, Tu H....
The Journal of Clinical Pharmacology. 62 (2022) 9 - p. 1094-1105 , 2022

Link: https://doi.org/10.1002/..

5

The era of immunogenomics/immunopharmacogenomics:

Zewde, Makda ; Kiyotani, Kazuma ; Park, Jae-Hyun...
Journal of Human Genetics. 63 (2018) 8 - p. 865-875 , 2018

Link: https://doi.org/10.1038/..

6

Hepatic and renal mechanisms underlying the osmopressor res..:

Mai, Tu H. ; Garland, Emily M. ; Diedrich, André.
Autonomic Neuroscience. 203 (2017) - p. 58-66 , 2017

Link: https://doi.org/10.1016/..

7

Characterization of the B-cell receptor repertoires in pean..:

Kiyotani, Kazuma ; Mai, Tu H ; Yamaguchi, Rui...
Journal of Human Genetics. 63 (2017) 2 - p. 239-248 , 2017

Link: https://doi.org/10.1038/..

8

Comparison of exome-based HLA class I genotyping tools: ide..:

Kiyotani, Kazuma ; Mai, Tu H ; Nakamura, Yusuke
Journal of Human Genetics. 62 (2016) 3 - p. 397-405 , 2016

Link: https://doi.org/10.1038/..

9

Calcitonin gene-related peptide (CGRP) in autonomic cardiov..:

Mai, Tu H. ; Wu, Jing ; Diedrich, André..
Journal of the American Society of Hypertension. 8 (2014) 5 - p. 286-296 , 2014

Link: https://doi.org/10.1016/..

10

Non‐Typhoidal Salmonella Colonization in Chickens and Human..:

Trung, N. V. ; Carrique‐Mas, J. J. ; Nghia, N. H....
Zoonoses and Public Health. 64 (2016) 2 - p. 94-99 , 2016

Link: https://doi.org/10.1111/..

11

Lipooligosaccharide Ligands from Respiratory Bacterial Path..:

Tu, Mai H. ; Brenza, Timothy M. ; Ketterer, Margaret R....
KONA Powder and Particle Journal. 41 (2024) 0 - p. 265-279 , 2024

Link: https://doi.org/10.14356..

12

Idiopathic pulmonary fibrosis therapy development: a clinic..:

Mai, Tu H ; Han, Lyrialle W ; Hsu, Joy C..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333628/. , 2023

Link: http://www.ncbi.nlm.nih...

13

Safety, Tolerability, and Pharmacokinetics of Benralizumab:..:

Cheung, Tommy Tsang ; Mai, Tu H ; Chia, Yen Lin...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885872/. , 2023

Link: http://www.ncbi.nlm.nih...

14

Safety, Tolerability, and Pharmacokinetics of Benralizumab:..:

Cheung, Tommy Tsang ; Mai, Tu H ; Chia, Yen Lin...
info:eu-repo/semantics/altIdentifier/doi/10.2147/DDDT.S392155. , 2023

Link: https://www.dovepress.co..

15

Hepatic and renal mechanisms underlying the osmopressor res..:

Mai, Tu H ; Garland, Emily M ; Diedrich, André.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5530865/. , 2017

Link: http://www.ncbi.nlm.nih...